TRARX Performance — T. Rowe Price Target 2005 Fund
Data updated: 2026-08-12
TRARX returned +4.46% year to date and +11.79% over one year to May 2026. Annualised returns are +9.72% over 3 years and +4.15% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $132, against $155 for the category, and to $112 over one year, against $121. Volatility over the past three years was 5.82% a year. In the 12 months to May 2026 the fund lost a net $8.0M, and assets reached $46.96M.
TRARX Growth of $100
What $100 invested in T. Rowe Price Target 2005 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | TRARX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $112 | $121 |
| 3 years (Jun 2023 – May 2026) | $132 | $155 |
| 5 years (Jun 2021 – May 2026) | $123 | $144 |
| Since data start (Sep 2019 – May 2026) | $147 | $187 |
TRARX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.46% |
| 1 year | +11.79% |
| 3 years (annualised) | +9.72% |
| 5 years (annualised) | +4.15% |
TRARX Annual Returns
Calendar-year total returns of T. Rowe Price Target 2005 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +4.46% |
| 2025 | +10.46% |
| 2024 | +7.20% |
| 2023 | +10.48% |
| 2022 | −12.56% |
| 2021 | +7.15% |
| 2020 | +10.74% |
| 2019 (Sep–Dec) | +3.94% |
TRARX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.4% | +1.4% | −3.1% | +3.4% | +1.4% | — | — | — | — | — | — | — |
| 2025 | +1.7% | +0.9% | −1.0% | +0.1% | +1.5% | +1.9% | +0.4% | +1.6% | +1.4% | +0.7% | +0.5% | +0.3% |
| 2024 | 0.0% | +1.2% | +1.7% | −2.0% | +2.2% | +0.7% | +1.9% | +1.4% | +1.3% | −1.4% | +2.0% | −1.9% |
| 2023 | +3.8% | −1.7% | +1.8% | +0.7% | −0.9% | +1.8% | +1.4% | −1.1% | −2.2% | −1.3% | +4.7% | +3.6% |
| 2022 | −2.6% | −1.2% | −0.4% | −4.2% | −0.1% | −4.1% | +3.6% | −2.5% | −5.4% | +1.7% | +4.1% | −1.8% |
| 2021 | −0.1% | +0.9% | +0.8% | +2.1% | +0.8% | +0.6% | +0.8% | +0.9% | −1.7% | +1.7% | −1.1% | +1.3% |
| 2020 | +0.3% | −2.1% | −8.5% | +5.8% | +2.9% | +1.9% | +3.0% | +2.1% | −1.3% | −0.6% | +5.1% | +2.3% |
| 2019 | — | — | — | — | — | — | — | — | +0.3% | +0.9% | +0.9% | +1.7% |
TRARX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 5.82%
- 3-year Sharpe ratio: 0.90 (vs 4.5% risk-free rate)
- Best month: +4.66% (Nov 2023)
- Worst month: −3.09% (Mar 2026)
TRARX Fund Flows
Monthly money in and out of T. Rowe Price Target 2005 Fund, from SEC Form N-PORT.
- 12-month net flow: −$8.0M
- 12-month gross sales (incl. reinvestments): $11.7M
- Sales ÷ redemptions: 0.60×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.4M | $1.9M | −$467K |
| Apr 2026 | $84K | $1.9M | −$1.8M |
| Mar 2026 | $1.4M | $618K | $778K |
| Feb 2026 | $101K | $491K | −$391K |
| Jan 2026 | $131K | $924K | −$793K |
| Dec 2025 | $3.5M | $2.3M | $1.2M |
| Nov 2025 | $877K | $1.5M | −$669K |
| Oct 2025 | $654K | $619K | $35K |
| Sep 2025 | $256K | $4.0M | −$3.7M |
| Aug 2025 | $1.6M | $2.7M | −$1.0M |
| Jul 2025 | $91K | $1.2M | −$1.1M |
| Jun 2025 | $1.6M | $1.5M | $103K |
TRARX Assets Under Management
Net assets of T. Rowe Price Target 2005 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $46.96M |
| 2026-02-28 | $47.73M |
| 2025-11-30 | $48.97M |
| 2025-08-31 | $52.03M |
| 2025-05-31 | $52.00M |
| 2025-02-28 | $49.08M |
| 2024-11-30 | $50.69M |
| 2024-08-31 | $50.96M |
| 2024-05-31 | $49.36M |
| 2024-02-29 | $50.07M |
| 2023-11-30 | $47.42M |
| 2023-08-31 | $48.08M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.